Alkermes
ALKS
#3090
Rank
A$7.34 B
Marketcap
A$44.48
Share price
0.75%
Change (1 day)
-9.09%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): A$0.63 Billion

According to Alkermes's latest financial reports the company's current earnings are A$1.52 Billion. In 2024 the company made an earning of A$0.70 Billion a decrease over its 2023 earnings that were of A$0.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.63 B-9.88%
2024 A$0.70 B-17.97%
2023 A$0.85 B-468.52%
2022 -A$0.24 Billion449.24%
2021 -A$42.32 Million-68.04%
2020 -A$0.14 Billion-52.1%
2019 -A$0.28 Billion64.49%
2018 -A$0.17 Billion-15.04%
2017 -A$0.2 Billion-34.2%
2016 -A$0.31 Billion-5.34%
2015 -A$0.32 Billion35084.97%
2014 -A$0.91 Million
2012 A$11.18 M-117.81%
2011 -A$62.81 Million-12.69%
2010 -A$71.93 Million94.3%
2009 -A$37.02 Million-117.7%
2008 A$0.20 B622.63%
2007 A$28.94 M
2004 -A$0.12 Billion-14.48%
2003 -A$0.14 Billion11.88%
2002 -A$0.12 Billion39.65%
2001 -A$85.68 Million5.73%
2000 -A$81.03 Million-28.91%
1999 -A$0.12 Billion237.28%
1998 -A$33.8 Million100.05%
1997 -A$16.9 Million-37.93%
1996 -A$27.22 Million82.72%
1995 -A$14.9 Million-26.79%
1994 -A$20.35 Million-72.78%
1993 -A$74.74 Million208.07%
1992 -A$24.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Acorda Therapeutics
ACOR
-A$0.41 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.10 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.81 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.85 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.72 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$2.66 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
-A$0.32 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.71 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
A$24.73 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland